World's Best Scientists 2026 revealed!
Margaret F. Bassendine

Margaret F. Bassendine

D-Index & Metrics

Medicine

D-Index
70
Citations
16651
World Ranking
20108
National Ranking
1806

Overview

Margaret F. Bassendine is affiliated with Newcastle University in the United Kingdom. Their research primarily spans the field of Medicine, with a focus on subfields including Epidemiology, Hepatology, Rheumatology, Infectious Diseases, and Surgery.

The main topics examined in their work include:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Pancreatitis Pathology and Treatment
  • Systemic Lupus Erythematosus Research
  • Peptidase Inhibition and Analysis
  • COVID-19 Clinical Research Studies
  • Alzheimer's disease research and treatments

Frequent co-authors who have collaborated on multiple publications with Bassendine are:

  • Simon H. Bridge
  • Simon D. Taylor-Robinson
  • Dermot Neely
  • Mark D. Gorrell
  • David Sheridan

Publications by Bassendine have appeared repeatedly in journals such as:

  • Journal of Diabetes
  • Journal of Alzheimer s Disease
  • Scientific Reports
  • European Journal of Rheumatology
  • Vaccines

Selected recent papers by Margaret F. Bassendine include:

  • COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?, 2020, Journal of Diabetes
  • Is Alzheimer's Disease a Liver Disease of the Brain?, 2020, Journal of Alzheimer s Disease
  • Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review, 2020, European Journal of Rheumatology

Other collaborative works where Bassendine contributed include publications such as:

  • Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis, 2022, Scientific Reports
  • Revisiting the Elusive Hepatitis C Vaccine, 2021, Vaccines

Best Publications

  • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

    Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg

  • Natural history of early primary biliary cirrhosis

    Jane V Metcalf;Harriet C Mitchison;Jeremy M Palmer;David E Jones

  • Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

    Søren U. Nielsen;Margaret F. Bassendine;Alastair D. Burt;Caroline Martin

  • Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

    Geoffrey Dusheiko;Janice Main;Howard Thomas;Olle Reichard

  • Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

    J Grove;A K Daly;M F Bassendine;C P Day

  • PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS

    S.J. Yeaman;D.J. Danner;D.J. Mutimer;S.P.M. Fussey

  • Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis

    Shelley P. M. Fussey;John R. Guest;Oliver F. W. James;Margaret F. Bassendine

  • Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

    P Michieletti;I R Wanless;A Katz;P J Scheuer

  • Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis?

    Harriet C. Mitchison;Margaret F. Bassendine;Alex Hendrick;Mark K. Bennett

  • Familial primary biliary cirrhosis reassessed: a geographically-based population study.

    David Ej Jones;Fiona E Watt;Jane V Metcalf;Margaret F Bassendine

  • Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C

    Belinda C. Smith;Jane Grove;Muna A. Guzail;Christopher P. Day

  • A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.

    H.C. Mitchison;J.M. Palmer;M.F. Bassendine;A.J. Watson

  • Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

    J Grove;A K Daly;M F Bassendine;E Gilvarry

  • The true impact of fatigue in primary biliary cirrhosis: a population study.

    Jennifer Goldblatt;Philip J.S. Taylor;Toby Lipman;Martin I. Prince

  • CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.

    Kosh Agarwal;David E.J Jones;Ann K Daly;Oliver F.W James

  • A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis

    Stephen Stewart;Martin Prince;Margaret Bassendine;Margaret Bassendine;Mark Hudson

  • Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region

    Shelley P. M. Fussey;Sohail T. Ali;John R. Guest;Oliver F. W. James

  • Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage.

    Christopher P. Day;Rumaisa Bashir;Oliver F. W. James;Margaret F. Bassendine

  • Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

    D. E. J. Jones;J. V. Metcalf;J. D. Collier;M. F. Bassendine

  • A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss.

    Harriet C. Mitchison;Margaret F. Bassendine;Archie J. Malcolm;Alex J. Watson

Frequent Co-Authors

Oliver F. W. James
Oliver F. W. James Newcastle University
Alastair D. Burt
Alastair D. Burt Newcastle University
David Jones
David Jones Newcastle University
Stephen J. Yeaman
Stephen J. Yeaman Newcastle University
Ann K. Daly
Ann K. Daly Newcastle University
Christopher P. Day
Christopher P. Day Newcastle University
John A. Kirby
John A. Kirby Newcastle University
Peter T. Donaldson
Peter T. Donaldson University of Newcastle Australia
Simon D. Taylor-Robinson
Simon D. Taylor-Robinson Imperial College London
Nikolai V. Naoumov
Nikolai V. Naoumov Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary online programs can open new doors for students interested in medicine or healthcare careers. For those looking to move into healthcare administration, pursuing one of the cahme accredited online mha programs list ensures a robust, industry-recognized education with flexibility to fit busy schedules.

Nurses seeking to advance their credentials without extensive in-person requirements can check out online rn to bsn no clinicals programs. These online RN to BSN pathways provide the opportunity to earn a bachelor’s degree efficiently from anywhere.

For those committed to the highest level of nursing practice, multiple options are available. The dnp online programs and dnp programs cater to those looking for either the fastest route or a more accessible journey to a Doctor of Nursing Practice.

These online degree pathways help future healthcare leaders, administrators, and advanced practice practitioners upskill quickly—often while maintaining their current jobs.

Best Scientists Citing Margaret F. Bassendine

Trending Scientists